The US Food and Drug Administration has suggested that its approval of the first generic version of Merck & Co.’s Proventil HFA (albuterol sulfate) metered dose inhaler may have at least some connection to the coronavirus outbreak.
Cipla’s ANDA for the product, which is indicated for treatment or prevention of bronchospasm and exercise-induced bronchospasm, was approved...




